http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CO-5261539-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05a203d85ee01909eaf728dc16f0f6cb
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00
filingDate 2000-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf8f152f1318a08e556bc782259fc330
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ce53b61c868edc5d79e3a4762fbc685
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89b2156e6791f30a29396ac397aebfc3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ba1b404b82634576eb601aacdd0f41a
publicationDate 2003-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CO-5261539-A1
titleOfInvention PHARMACEUTICALLY ACTIVE COMPOUNDS
abstract A compound of general formula (I): <EMI FILE = "00077032_1" ID = "1" MFI = JPEG> or a pharmaceutically acceptable salt and / or solvate thereof in which: X represents 0 or NR5, R1 represents H, lower alkyl, Het, alkylHet, aryl or alkylaryl (these last five groups being optionally substituted and / or terminated with one or more substituents selected from halogen, cyano, nitro, lower alkyl, halogen (lower alkyl), OR6, OC (O) R7, C (O) R8, C (O) OR9, C (O) NR10R11, NR12R13 and SO2NR14R15 R2 represents H, halogen, cyano, nitro, OR6, OC (O) R7, C (O) R8, C ( O) OR9, C (O) NR10R11, NR12R13 and SO2NR14R15, lower alkyl, het, alkylHet, aryl or alkylaryl (these last five groups being optionally substituted and / or terminated with one or more substituents selected from halogen, cyano, nitro, alkyl lower, halogen (lower alkyl), OR6, OC (O) R7, C (O) R8, C (O) OR9, C (O) NR10R11, NR12R13 and SO2NR14R15) .R3 represents H, lower alkyl, alkylHet or alkylaryl ( is it so of these last three groups optionally substituted and / or terminated with one or more substituents selected from halogen, cyano, nitro, lower alkyl, halogen (lower alkyl), OR6, OC (O) R7, C (O) R8, C (O ) OR9, C (O) NR10R11, NR12R13 and SO2NR14R15). R4 represents H, halogen, cyano, nitro, halogen (lower alkyl), OR6, OC (O) R7, C (O) R8, C (O) OR9, C (O) NR10R11, NR12R13, NR16Y (O) R17, N [Y (O) R17] 2, SOR18, SO2R19, C (O) AZ, lower alkyl, lower alkenyl, lower alkynyl, Het, alkylHet, aryl, alkylaryl (these last seven groups being optionally substituted and / or terminated with one or more substituents selected from halogen, cyano, nitro, lower alkyl, halogen (lower alkyl), OR6, OC (O) R7, C (O) R8, C (O) OR9, C (O) NR10R11, NR12R13 and SO2NR14R15) . Y represents C or S (O) A represents lower alkylene Z represents OR6, halogen, Het or aryl (these last two groups being optionally substituted with one or more substituents selected from halogen, cyano, ...
priorityDate 1999-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454973655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458427722

Total number of triples: 30.